SeraCare Life Sciences said it will be bought by an affiliate of private-equity firm Linden Capital Partners for $80.8 million.
SeraCare to go private in $81 million deal
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.